Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA

    May 2011
    A. W. Rafi, Randy H. Katz
    Image of study
    TLDR The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.
    In a pilot study from April to December 2010, 15 male patients with androgenic alopecia were treated with a new regimen, including a topical combination called NuH Hair, which contains finasteride, dutasteride, and minoxidil, with optional additions of Rogaine foam, Propecia, and ketoconazole shampoo. The group comprised 10 atopic and 5 non-atopic individuals, aged 24 to 72. All patients experienced significant hair growth, with those using the full four-component regimen seeing results in as little as 30 days, and those using only NuH Hair seeing results after 3 months. The study, which used photographs for documentation and monthly assessments for compliance, found no side effects and suggested the need for a larger, controlled study.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 1000+ results

      community Average r/bald user complaining

      in Satire  386 upvotes 6 days ago
      Hair loss treatments like Minoxidil, finasteride, and RU58841, focusing on their effectiveness and side effects. It also highlights the disparity in medical research funding between hair loss and conditions like endometriosis.

      community Bee venom better than minoxidil?

      in Research/Science  1042 upvotes 1 week ago
      Bee venom at 0.001% concentration was more effective than 2% minoxidil in promoting hair growth in mice, possibly due to increased growth factors and reduced inflammation. Caution is advised due to potential allergic reactions and the reliance on animal data.

      community So we’re just ok with taking a research chemical now?

      in Treatment  177 upvotes 4 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

      community Androgenic alopecia exclusively on the vertex of the scalp

      in Chat  6 upvotes 1 year ago
      A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hair loss is common among men.

    Related Research

    8 / 8 results